|
|
 |
A First Class stamp testrosity canada
ZURICH, Oct 17 (Reuters) - Actelion, Europe'slargest biotech company, confirmed its full-year outlook onThursday ahead of a widely anticipated approval of its big drughope Opsumit by U.S. health regulators later this week.
2021-2-2 3:54:50 |
|
|
|
